Adrenal SGLT1 or SGLT2 as predictors of atherosclerosis under chronic stress based on a computer algorithm

Background Chronic stress promotes the development of atherosclerosis, causing disruptions in the body’s hormone levels and changes in the structural function of organs. Objective The purpose of this study was to investigate the pathological changes in the adrenal gland in a model of atherosclerosis...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	PeerJ
المؤلفون الرئيسيون:	Jianyi Li, Lingbing Meng, Dishan Wu, Hongxuan Xu, Xing Hu, Gaifeng Hu, Yuhui Chen, Jiapei Xu, Tao Gong, Deping Liu
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	PeerJ Inc. 2023-08-01
الموضوعات:	SGLT1 SGLT2 Adrenal gland Atherosclerosis Chronic stress Predictors
الوصول للمادة أونلاين:	https://peerj.com/articles/15647.pdf

مواد مشابهة

SGLT1/2 as the potential biomarkers of renal damage under Apoe−/− and chronic stress via the BP neural network model and support vector machine
حسب: Gai-feng Hu, وآخرون
منشور في: (2022-08-01)

Research Progress of SGLT2 Inhibitors in Cancer Treatment
حسب: Miao X, وآخرون
منشور في: (2025-01-01)

Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis
حسب: Liu Yang, وآخرون
منشور في: (2022-12-01)

A study of SGLT2 inhibitors on levels of plasma atherogenesis biomarkers in diabetes
حسب: Naveenkumar Nallathambi, وآخرون
منشور في: (2024-11-01)

Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
حسب: Annalisa Capuano, وآخرون
منشور في: (2022-11-01)

Comparative cardiovascular risks of canagliflozin and selective SGLT2 inhibitors in type 2 diabetes
حسب: Edy Kornelius, وآخرون
منشور في: (2025-10-01)

The Influence of Performance Status, Inflammation, and Nutrition on the Impact of SGLT2 Inhibitors on Cancer Outcomes
حسب: Diego Rivas‐Otero, وآخرون
منشور في: (2025-03-01)

Safety of SGLT2 inhibitors in very elderly diabetic type 2 patients in real life
حسب: Ramón Baeza-Trinidad, وآخرون
منشور في: (2023-07-01)

The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition
حسب: Muhammad Saad, وآخرون
منشور في: (2018-11-01)

Three Levels of Disease Modification with SGLT-2 Inhibitors: Holy Grail in Vasculopathy
حسب: Archit Dhaiya; Rajeev Sharma; Nagendra Bhoopathy; Rajeev Agarwal
منشور في: (2023-07-01)

The Effect Of SGLT-2 Inhibitors On Improving Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
حسب: Wasef Sayeh, وآخرون
منشور في: (2023-12-01)

Navigating the therapeutic landscape of SGLT2 inhibitors in diabetes management: exploring efficacy and emerging concerns
حسب: Farazul Hoda, وآخرون
منشور في: (2024-11-01)

The Potential Impact of SGLT2-I in Diabetic Foot Prevention: Promising Pathophysiologic Implications, State of the Art, and Future Perspectives—A Narrative Review
حسب: Giuseppe Miceli, وآخرون
منشور في: (2024-11-01)

SGLT2 inhibitors: control of glycemia and nephroprotection properties
حسب: A. A. Volodin, وآخرون
منشور في: (2018-02-01)

SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control
حسب: Canan Ersoy
منشور في: (2020-01-01)

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study
حسب: Maria Elena Lunati, وآخرون
منشور في: (2022-09-01)

SGLT2-Inhibitors - significant role in Heart Failure treatment
حسب: Karol Wielgus, وآخرون
منشور في: (2024-05-01)

Is GFR decline induced by SGLT2 inhibitor of clinical importance?
حسب: Merve Günes-Altan, وآخرون
منشور في: (2024-05-01)

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
حسب: Chiara Maria Assunta Cefalo, وآخرون
منشور في: (2019-02-01)

SGLT-2 inhibitors in chronic peritoneal dialysis patients: a follow-up study
حسب: Jia-Wen Lai, وآخرون
منشور في: (2024-07-01)

SGLT2 Inhibition in Acute Myocardial Infarction—A Comprehensive Review
حسب: Martin Benedikt, وآخرون
منشور في: (2023-01-01)

The potential anti-arrhythmic effect of SGLT2 inhibitors
حسب: Hong-Yi Duan, وآخرون
منشور في: (2024-07-01)

Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus
حسب: Matthew Cagliostro, وآخرون
منشور في: (2022-06-01)

Benefits of SGLT2 inhibitors in arrhythmias
حسب: Jinghan Gao, وآخرون
منشور في: (2022-10-01)

Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice
حسب: Claire Gerber, وآخرون
منشور في: (2021-08-01)

Cardiac Fibrosis: Mechanistic Discoveries Linked to SGLT2 Inhibitors
حسب: Filip Rolski, وآخرون
منشور في: (2025-02-01)

Ketoacidosis and SGLT2 Inhibitors: A Narrative Review
حسب: Carmela Morace, وآخرون
منشور في: (2024-05-01)

The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report
حسب: Diana Alegre-González, وآخرون
منشور في: (2025-10-01)

SGLT-2 inhibitors in heart failure: a literature review on mechanisms, efficacy and safety
حسب: Klaudia Kułak, وآخرون
منشور في: (2024-07-01)

¿Combinamos AR-GLP1 + i-SGLT2? Sí o no
حسب: Claudia Folino
منشور في: (2024-10-01)

Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus
حسب: Yuta Suzuki, وآخرون
منشور في: (2022-05-01)

High-Dose Liraglutide and SGLT2 Inhibitor: A Promising Combination
حسب: Marvin Wei Jie Chua
منشور في: (2021-12-01)

SGLT2 inhibition attenuates diabetic tubulopathy by suppressing SGK1-mediated pyroptosis
حسب: Xu Shi, وآخرون
منشور في: (2025-09-01)

Is cancer incidence modified by SGLT2 inhibitors?
حسب: Lev M. Berstein
منشور في: (2019-10-01)

The Effects of SGLT2 Inhibitors on Lipid Metabolism
حسب: Zsolt Szekeres, وآخرون
منشور في: (2021-02-01)

Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle‐stimulated endothelial senescence and dysfunction: protective effect of gliflozins
حسب: Sin-Hee Park, وآخرون
منشور في: (2021-03-01)

The Impact of SGLT1 Inhibition on Frailty and Sarcopenia: A Mediation Mendelian Randomization Study
حسب: Bang‐Bang Huang, وآخرون
منشور في: (2024-12-01)

Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy
حسب: Lakshini Y. Herat, وآخرون
منشور في: (2022-12-01)

SGLT-2 inhibitors as novel treatments of multiple organ fibrosis
حسب: Junpei Hu, وآخرون
منشور في: (2024-04-01)

Tópicos Emergentes em Insuficiência Cardíaca: Inibidores do Cotransportador Sódio-Glicose 2 (iSGLT2) na IC
حسب: Edimar Alcides Bocchi, وآخرون
منشور في: (2021-03-01)